21-31355338-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001353688.1(TIAM1):​c.-653-15916A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.314 in 151,880 control chromosomes in the GnomAD database, including 8,082 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 8082 hom., cov: 31)

Consequence

TIAM1
NM_001353688.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.00

Publications

2 publications found
Variant links:
Genes affected
TIAM1 (HGNC:11805): (TIAM Rac1 associated GEF 1) This gene encodes a RAC1-specific guanine nucleotide exchange factor (GEF). GEFs mediate the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP). The binding of GTP induces a conformational change in RAC1 that allows downstream effectors to bind and transduce a signal. This gene thus regulates RAC1 signaling pathways that affect cell shape, migration, adhesion, growth, survival, and polarity, as well as influencing actin cytoskeletal formation, endocytosis, and membrane trafficking. This gene thus plays an important role in cell invasion, metastasis, and carcinogenesis. In addition to RAC1, the encoded protein activates additional Rho-like GTPases such as CDC42, RAC2, RAC3 and RHOA. This gene encodes multiple protein isoforms that experience a diverse array of intramolecular, protein-protein, and phosphorylation interactions as well as phosphoinositide binding. Both the longer and shorter isoforms have C-terminal Dbl homology (DH) and pleckstrin homology (PH) domains while only the longer isoforms of this gene have the N-terminal myristoylation site and the downstream N-terminal PH domain, ras-binding domain (RBD), and PSD-95/DlgA/ZO-1 (PDZ) domain. [provided by RefSeq, Jul 2017]
TIAM1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with language delay and seizures
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.42 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001353688.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TIAM1
NM_001353688.1
c.-653-15916A>G
intron
N/ANP_001340617.1
TIAM1
NM_001353689.1
c.-368-15916A>G
intron
N/ANP_001340618.1
TIAM1
NM_001353690.1
c.-368-15916A>G
intron
N/ANP_001340619.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TIAM1
ENST00000286827.7
TSL:5
c.-368-15916A>G
intron
N/AENSP00000286827.3
TIAM1
ENST00000469412.5
TSL:2
n.113-15916A>G
intron
N/A
ENSG00000286643
ENST00000653041.1
n.292-1973T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.314
AC:
47671
AN:
151760
Hom.:
8068
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.189
Gnomad AMI
AF:
0.256
Gnomad AMR
AF:
0.427
Gnomad ASJ
AF:
0.300
Gnomad EAS
AF:
0.403
Gnomad SAS
AF:
0.242
Gnomad FIN
AF:
0.391
Gnomad MID
AF:
0.196
Gnomad NFE
AF:
0.354
Gnomad OTH
AF:
0.312
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.314
AC:
47713
AN:
151880
Hom.:
8082
Cov.:
31
AF XY:
0.317
AC XY:
23539
AN XY:
74206
show subpopulations
African (AFR)
AF:
0.188
AC:
7805
AN:
41452
American (AMR)
AF:
0.428
AC:
6541
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.300
AC:
1041
AN:
3472
East Asian (EAS)
AF:
0.403
AC:
2070
AN:
5134
South Asian (SAS)
AF:
0.242
AC:
1166
AN:
4810
European-Finnish (FIN)
AF:
0.391
AC:
4106
AN:
10500
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.354
AC:
24029
AN:
67928
Other (OTH)
AF:
0.314
AC:
662
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1620
3239
4859
6478
8098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
474
948
1422
1896
2370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.341
Hom.:
34722
Bravo
AF:
0.319
Asia WGS
AF:
0.301
AC:
1044
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.19
DANN
Benign
0.35
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16988159; hg19: chr21-32727653; API